The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Saved in:
| Title: | The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial. |
|---|---|
| Authors: | Patel NR; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Hospital, Boston, MA., Cunoosamy DM; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Fagerås M; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Taib Z; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Asimus S; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Hegelund-Myrbäck T; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Lundin S; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Pardali K; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Kurian N; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Ersdal E; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Kristensson C; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Korsback K; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Palmér R; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Brown MN; Innovative Medicines and Early Development, AstraZeneca, Boston, MA, USA., Greenaway S; Quintiles Drug Research Unit at Guy's Hospital, London., Siew L; Quintiles Drug Research Unit at Guy's Hospital, London., Clarke GW; Quintiles Drug Research Unit at Guy's Hospital, London.; Department of Cardiothoracic Pharmacology, NHLI, Imperial College London, London, UK., Rennard SI; Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA.; Clinical Discovery Unit, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK., Make BJ; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO., Wise RA; Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Jansson P; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden. |
| Source: | International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2018 Mar 27; Vol. 13, pp. 1009-1019. Date of Electronic Publication: 2018 Mar 27 (Print Publication: 2018). |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29628759 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Patel+NR%22">Patel NR</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cunoosamy+DM%22">Cunoosamy DM</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Fagerås+M%22">Fagerås M</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Taib+Z%22">Taib Z</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Asimus+S%22">Asimus S</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Hegelund-Myrbäck+T%22">Hegelund-Myrbäck T</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Lundin+S%22">Lundin S</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Pardali+K%22">Pardali K</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Kurian+N%22">Kurian N</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Ersdal+E%22">Ersdal E</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Kristensson+C%22">Kristensson C</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Korsback+K%22">Korsback K</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Palmér+R%22">Palmér R</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Brown+MN%22">Brown MN</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Greenaway+S%22">Greenaway S</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.<br /><searchLink fieldCode="AU" term="%22Siew+L%22">Siew L</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.<br /><searchLink fieldCode="AU" term="%22Clarke+GW%22">Clarke GW</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.; Department of Cardiothoracic Pharmacology, NHLI, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rennard+SI%22">Rennard SI</searchLink>; Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA.; Clinical Discovery Unit, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Make+BJ%22">Make BJ</searchLink>; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO.<br /><searchLink fieldCode="AU" term="%22Wise+RA%22">Wise RA</searchLink>; Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jansson+P%22">Jansson P</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101273481%22">International journal of chronic obstructive pulmonary disease</searchLink> [Int J Chron Obstruct Pulmon Dis] 2018 Mar 27; Vol. 13, pp. 1009-1019. <i>Date of Electronic Publication: </i>2018 Mar 27 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22DOVE+Medical+Press%22">DOVE Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101273481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1178-2005 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211769106%22">11769106 </searchLink><i>NLM ISO Abbreviation: </i>Int J Chron Obstruct Pulmon Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29628759 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/COPD.S150576 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1009 Titles: – TitleFull: The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patel NR – PersonEntity: Name: NameFull: Cunoosamy DM – PersonEntity: Name: NameFull: Fagerås M – PersonEntity: Name: NameFull: Taib Z – PersonEntity: Name: NameFull: Asimus S – PersonEntity: Name: NameFull: Hegelund-Myrbäck T – PersonEntity: Name: NameFull: Lundin S – PersonEntity: Name: NameFull: Pardali K – PersonEntity: Name: NameFull: Kurian N – PersonEntity: Name: NameFull: Ersdal E – PersonEntity: Name: NameFull: Kristensson C – PersonEntity: Name: NameFull: Korsback K – PersonEntity: Name: NameFull: Palmér R – PersonEntity: Name: NameFull: Brown MN – PersonEntity: Name: NameFull: Greenaway S – PersonEntity: Name: NameFull: Siew L – PersonEntity: Name: NameFull: Clarke GW – PersonEntity: Name: NameFull: Rennard SI – PersonEntity: Name: NameFull: Make BJ – PersonEntity: Name: NameFull: Wise RA – PersonEntity: Name: NameFull: Jansson P IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 03 Text: 2018 Mar 27 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1178-2005 Numbering: – Type: volume Value: 13 Titles: – TitleFull: International journal of chronic obstructive pulmonary disease Type: main |
| ResultId | 1 |